Mosio for Research

Mosio for Research is a digital health and mobile messaging startup founded in 2007 and based in the United States. The company's slogan, "Mosio helps researchers engage, retain, and collect data from study subjects more efficiently and effectively with SMS," succinctly captures its purpose. Mosio focuses on enabling clinical research teams to improve patient adherence, communications, and data collection using SMS as the primary channel. The startup's services are tailored to clinical trial sponsors, including pharma and biotech firms, cancer centers, clinical research organizations, and NIH-funded studies. Through its software, Mosio offers various benefits to research teams, such as interactive dosing reminders, medication adherence alerts, automated data collection, and two-way text messaging for efficient communication. The platform also facilitates the automation of processes and personalized messaging based on individual participant timelines. By leveraging SMS, Mosio aims to resolve common challenges faced by researchers, including improving patient engagement, retention, and the overall effectiveness of data collection efforts. Mosio's unique value proposition lies in its ability to integrate seamlessly with third-party clinical trials software, further enhancing its value to research teams. Although there is no publicly available information regarding the startup's latest investment or the associated investors, the company's focus on addressing critical communication and data collection needs within clinical research positions it as an innovative player in the digital health and pharmaceutical industries. For venture capital firms seeking investment opportunities in the digital health and mobile messaging sectors, Mosio presents a compelling proposition with the potential to drive significant impact within the realm of clinical research. The startup's clear positioning, industry focus, and impactful solutions make it a noteworthy contender for venture investment consideration.